08/11/2010 7:01 AM
Valeant and Biovail Set Date for Shareholders Meetings

08/05/2010 7:04 AM
Biovail Reports Second-Quarter 2010 Financial Results

08/05/2010 6:59 AM
Biovail Declares Quarterly Dividend

07/23/2010 12:01 PM
Biovail Announces Second-Quarter 2010 Earnings Release, Conference-Call Details

06/22/2010 4:04 PM
Biovail and MedGenesis Announce Grant from The Michael J. Fox Foundation for the Development of GDNF

Go to News Archive

Tools

	Investment Calculator Email Alerts

Resources

Q2 2010 Financial Results

Valeant - Biovail Analyst Investor Presentation

Biovail - Valeant Merger Conference Call

Biovail's Product Pipeline

Pimavanserin Schizophrenia Co-Therapy - Phase 2 Data

Aplenzin Prescribing Information

Nitoman Prescribing Information

Xenazine Prescribing Information

Xenazine Medication Guide

Corporate Fact Sheet

IMPORTANT: Income Tax Information for Canadian Resident Shareholders

Download Adobe Acrobat Reader

Events

� 2007 Biovail Corporation - All Rights Reserved (BIO113B0602)

Privacy Policy | Disclaimers